Murphy Pohlad Asset Management’s Bio-Techne TECH Stock Holding History

Murphy Pohlad Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-38,260	Closed	-$4.63M	–	114
2021 Q3	$4.63M	Hold	38,260	–	–	1.89%	15
2021 Q2	$4.31M	Hold	38,260	–	–	1.74%	17
2021 Q1	$3.65M	Hold	38,260	–	–	1.59%	21
2020 Q4	$3.04M	Sell	38,260 -1,980	-5%	-$143K	1.51%	22
2020 Q3	$2.49M	Sell	40,240 -760	-2%	-$49.4K	1.32%	29
2020 Q2	$2.71M	Hold	41,000	–	–	1.51%	24
2020 Q1	$1.94M	Hold	41,000	–	–	1.32%	29
2019 Q4	$2.25M	Hold	41,000	–	–	1.23%	32
2019 Q3	$2M	Hold	41,000	–	–	1.22%	33
2019 Q2	$2.14M	Sell	41,000 -30,600	-43%	-$1.54M	1.28%	32
2019 Q1	$3.55M	Buy	+71,600	New	+$3.22M	2.15%	12

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Murphy Pohlad Asset Management's TECH Position: Q4 2021 in Review

Murphy Pohlad Asset Management sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 38,260 shares — an estimated $4.63M sold.

Murphy Pohlad Asset Management first reported a position in TECH in Q1 2019 and held it in 11 quarters. The position peaked at $4.63M in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

Murphy Pohlad Asset Management reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
Murphy Pohlad Asset Management sold 38,260 Bio-Techne shares in Q4 2021, an estimated $4.63M.
Murphy Pohlad Asset Management first reported a position in Bio-Techne in Q1 2019 and held it in 11 quarters.
Murphy Pohlad Asset Management's Bio-Techne position peaked at $4.63M in Q3 2021.
575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on Murphy Pohlad Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.